Reference

1. WHO. Listings of WHO’s response to COVID-19. World Health Organization. 2021.
2. Shamim S, Khan M, Kharaba Z, et al. Potential strategies for combating COVID-19. Arch Virol. 2020;165(11):2419-2438. https://doi.org/10.1007/s00705-020-04768-3
3. Visacri MB, Figueiredo IV, Lima TM. Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Social AdmPharm. 2021;17(1):1799-1806. https://doi.org/10.1016/j.sapharm
4. Sami S, Marma K, Chakraborty A, et al. A comprehensive review on global contributions and recognition of pharmacyprofessionals amidst COVID-19 pandemic: moving from present to future. Futur J Pharm Sci. 2021;7:119. https://doi.org/10.1186/s43094-021-00273-9
5. Elbeddini A, Prabaharan T, Almasalkhi S, et al. Pharmacists and COVID-19. J Pharm Policy Pract. 2020;13:36. https://doi.org/10.1186/s40545-020-00241-3
6. Kretchy I, Asiedu-Danso M, Kretchy J. Medication management and adherence during the COVID-19 pandemic: Perspectives andexperiences from low-and middle-income countries. Res Social Adm Pharm. 2021;17(1):2023-2026. https://doi.org/10.1016/j.sapharm.2020.04.007
7. Koster ES, Philbert D, Bouvy ML. Impact of the COVID-19 epidemic on the provision of pharmaceutical care in communitypharmacies. Res Social Adm Pharm. 2021;17(1):2002-2004. https://doi.org/10.1016/j.sapharm.2020.07.001
8. Arain, S., Thalapparambath, R., & Al Ghamdi, F. H. (2021). COVID?19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department. Research in Social & Administrative Pharmacy, 17, 2009–2011. 10.1016/j.sapharm.2020.05.016 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Austin, Z. , & Gregory, P. (2021). Resilience in the time of pandemic: The experience of community pharmacists during COVID?19. Research in Social & Administrative Pharmacy, 17, 1867–1875. 10.1016/j.sapharm.2020.05.027 [PMC free article]
10. Bahlol, M, & Dewey, R. S. (2021). Pandemic preparedness of community pharmacies for COVID?19. Research in Social & Administrative Pharmacy, 17, 1888–1896. 10.1016/j.sapharm.2020.05.009 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Cadogan, C. A. , & Hughes, C. M. (2021). On the frontline against COVID?19: Community pharmacists' contribution during a public health crisis. Research in Social & Administrative Pharmacy, 17, 2032–2035. 10.1016/j.sapharm.2020.03.015 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Casey, M. M. , Sorensen, T. D. , Elias, W. , Knudson, A. , & Gregg, W. (2010). Current practices and state regulations regarding telepharmacy in rural hospitals. American Journal of Health?System Pharmacy, 67, 1085–1092. 10.2146/ajhp090531 [PubMed] [CrossRef] [Google Scholar]
13. Domeyer, P. , Katsari, V. , & Mariolis, A. (2020). Chronic non?communicable diseases: A sacrifice on the altar of COVID?19? British Journal of General Practice, 70, 281. 10.3399/bjgp20X710057 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Fong, M. W. , Gao, H. , Wong, J. Y. , Xiao, J. , Shiu, E. Y. C. , Ryu, S. , & Cowling, B. J. (2020). Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings?social distancing measures. Emerging Infectious Diseases, 26, 976–984. 10.3201/eid2605.190995 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Ibrahim, O. M. , Ibrahim, R. M. , Z Al Meslamani, A. , & Al Mazrouei, N. (2020). Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. Journal of Telemedicine and Telecare, 1357633X20964347. 10.1177/1357633X20964347 [PubMed] [CrossRef] [Google Scholar].